BJL
ATYR

Brighton Jones LLC’s aTyr Pharma ATYR Stock Holding History

Brighton Jones LLC’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.84K Buy
+11,458
New +$7.48K ﹤0.01% 1417

Other funds holding ATYR

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
HWM
Hohimer Wealth Management Seattle, Washington $1B AUM 33.02% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
AWF
Alpha Wealth Funds Park City, Utah $183M AUM 8.96% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Brighton Jones LLC's ATYR Position: Q2 2026 in Review

Brighton Jones LLC opened a new position in aTyr Pharma (ATYR) in Q2 2026: 11,458 shares worth $6.84K. The stake represents ﹤0.01% of the portfolio and ranks #1417 among its holdings.

39 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Brighton Jones LLC held 11,458 shares of aTyr Pharma worth $6.84K as of Q2 2026.
  • aTyr Pharma was a new Brighton Jones LLC position in Q2 2026.
  • aTyr Pharma made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1417 holding.
  • 39 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.